JUL 12, 2018 11:25 PM PDT

Genetically Engineered Cannabidiol On the Horizon?

WRITTEN BY: Mauri Brueggeman

The Federal Drug Administration (FDA) in the United States very recently approved Epidiolex, the first phytocannabinoid based pharmaceutical using cannabidiol extracted from the Cannabis sativa plant, which was developed to treat intractable seizures in pediatric patients. The US is poised at a crossroads.  The Drug Enforcement Agency (DEA) has until September 2018 to update the drug schedule status of the cannabidiol (CBD) in Epidiolex; it needs to be removed from the list of Schedule I drugs, the grouping which means that it has no medicinal value and is highly addictive, in order for US doctors to prescribe it.  With this FDA approval the longstanding argument, that cannabis-based products like CBD have no medicinal value, is tenuous at best. 

Researchers are optimistic that CBD, as a category, will be moved from the Schedule I list to a lesser regulated list.  This broad move would allow researchers to jump through fewer hoops to allow for easier study of this non-intoxicating compound.  One article author in Nature Communications this month quoted a cannabis researcher who said, “At the very least, the DEA ought to grant researchers an exemption permitting them to study CBD”.

Other areas in the world are not only producing cannabis and cannabinoids for medicinal use, they are genetically engineering cannabinoids using bacteria and yeast.  One of the challenges of plant-based products in demand, is that the ability to extract the amounts needed becomes untenable.  Some of these compounds, CBD or terpenes for example, are found in the plant at small levels.  By creating genetically engineered CBD, there are some scientists in countries like Canada that are preparing for higher demand.  Genetic engineering (GE) involves adding new DNA to an organism to imbue or enhance some component of the original, un-modified, entity. 

We have seen GE in agriculture, animals, and now perhaps plant-based medicine.  It is a remarkable feat of science that humans have derived a way to do this but there are concerns.  GE critics are troubled by the lack of inadequate testing for harmful effects on animals or the environment.  There are specific GE concerns spanning allergy development, increases in mutagenesis, antibiotic resistance, environmental damage, and what is called genetic pollution.  Once the engineered organisms or products enter the closest biome, they cannot be controlled or “cleaned up”.  There are many non-genetically modified organism (non-GMO) based products because of these apprehensions.  It raises some ethical questions also.  Alternatives include advanced crossbreeding approaches to generate better progeny.

To be sure, there are scientists in other countries preparing to forge ahead using biotechnological advances like this to help provide medicinal cannabinoids to consumers and researchers for further study. 

Sources:  Nature CommunicationsGrace Communications Foundation, AgBiosafety, Biotechnology Letters, The Californian,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
JUN 18, 2020
Health & Medicine
People Taking Medicinal Cannabis Report Greater Well-Being
JUN 18, 2020
People Taking Medicinal Cannabis Report Greater Well-Being
Legalization of medicinal cannabis is now fairly widespread, yet there's been a paucity of data collected on patient exp ...
JUN 26, 2020
Cannabis Sciences
Cannabis Smoke Contains 110 Toxic Chemicals
JUN 26, 2020
Cannabis Smoke Contains 110 Toxic Chemicals
Researchers from the University of Alberta in Canada have found that cannabis smoke contains 110 potentially toxic chemi ...
JUL 01, 2020
Health & Medicine
Could THC Help Advanced Alzheimer's Symptoms?
JUL 01, 2020
Could THC Help Advanced Alzheimer's Symptoms?
More than 5 million Americans are living with Alzheimer's disease (AD) according to the Alzheimer's Organization. When t ...
JUL 22, 2020
Immunology
CBD May Reduce Cytokine Storm & Lung Inflammation in COVID-19
JUL 22, 2020
CBD May Reduce Cytokine Storm & Lung Inflammation in COVID-19
Initial studies of cannabidiol’s impact of classic symptoms of lung damage in severe cases of COVID-19 provide a p ...
JUL 29, 2020
Cannabis Sciences
Stimulants, Cannabis, and Medical Cannabis Laws
JUL 29, 2020
Stimulants, Cannabis, and Medical Cannabis Laws
Lesbian, gay, and bisexual populations may be at a higher risk of prescription stimulant use, based on a new examination ...
AUG 11, 2020
Cannabis Sciences
High THC Cannabis Linked to Anxiety
AUG 11, 2020
High THC Cannabis Linked to Anxiety
Researchers have found that people who use strains of cannabis high in tetrahydrocannabinol (THC), the psychoactive comp ...
Loading Comments...